Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

673
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
673

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancement of in vivo 7T magnetic resonance neuroimaging via flexible metasurfaces.

Npj imaging·2026
Same author

Transformer Enabled Half Z‑spectrum Sampling B<sub>0</sub> Inhomogeneity Correction for GluCEST and NOE MRI.

Chemical & biomedical imaging·2026
Same author

Diffuse nuclear Overhauser effect MRI contrast changes detected in multiple sclerosis subjects at 7T.

Brain communications·2025
Same author

Medial temporal lobe gray matter microstructure in preclinical Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2024
Same author

In vivo <math><mrow><msubsup><mi>B</mi> <mn>1</mn> <mo>+</mo></msubsup></mrow></math> enhancement of calf MRI at 7 T via optimized flexible metasurfaces.

Magnetic resonance in medicine·2024
Same author

Early-stage mapping of macromolecular content in APP<sup>NL-F</sup> mouse model of Alzheimer's disease using nuclear Overhauser effect MRI.

Frontiers in aging neuroscience·2023
Same journal

Gut microbiota alterations in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.

Journal of Alzheimer's disease : JAD·2026
Same journal

Stage-dependent relationship between sleep duration and cortical tau deposition in cognitively impaired individuals: A cross-sectional study.

Journal of Alzheimer's disease : JAD·2026
Same journal

Multilayer brain connectivity and long-term cognitive changes in individuals at risk for Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2026
Same journal

The creation and verification of a detection model for mild cognitive impairment by employing eye-tracking and gait metrics.

Journal of Alzheimer's disease : JAD·2026
Same journal

Compartment-specific analysis reveals disrupted astrocytic calcium transients in anesthetized Alzheimer's disease mice.

Journal of Alzheimer's disease : JAD·2026
Same journal

<i>APOE</i> ε4-specific associations between agitation, cerebrospinal fluid biomarkers, and cognitive decline in cognitively impaired patients.

Journal of Alzheimer's disease : JAD·2026
See all related articles

Related Experiment Video

Updated: Sep 15, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

Alzheimer's disease classification using mutual information generated graph convolutional network for functional MRI.

Yinghua Fu1, Li Jiang1, John Detre2

  • 1Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

Journal of Alzheimer'S Disease : JAD
|July 15, 2025
PubMed
Summary
This summary is machine-generated.

Mutual information (MI) connectomes effectively distinguish Alzheimer's disease (AD) stages from normal controls (NC). This novel approach using graph convolutional networks (GCNs) shows high accuracy in identifying cognitive decline.

Keywords:
Alzheimer's diseasefunctional magnetic resonance imaginggraph convolutional networkmutual information

More Related Videos

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.0K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.8K

Related Experiment Videos

Last Updated: Sep 15, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.0K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.8K

Area of Science:

  • Neuroscience
  • Artificial Intelligence
  • Medical Imaging

Background:

  • High-order cognitive functions rely on inter-regional brain communication, quantifiable by mutual information (MI).
  • Alzheimer's disease (AD) impairs cognitive functions, suggesting alterations in inter-regional MI that require investigation.
  • Current understanding of AD's impact on inter-regional brain communication, specifically MI, remains limited.

Purpose of the Study:

  • To determine if inter-regional MI can differentiate Alzheimer's disease (AD) stages from normal controls (NC).
  • To employ a connectome-based graph convolutional network (GCN) for predicting AD stages using MI.
  • To compare the efficacy of MI-based connectomes against other connectivity measures.

Main Methods:

  • Mutual information (MI) was computed between brain region time series to create connectomes.
  • A multi-level connectome-based GCN (MLC-GCN) processed these connectomes for spatio-temporal feature extraction.
  • The model was validated on 552 subjects from ADNI and OASIS3 datasets using 5-fold cross-validation.

Main Results:

  • The MI-based connectome achieved superior prediction accuracy (87.72% ADNI2, 84.11% OASIS3) and Area Under the Curve (0.96 for both).
  • Key MI features were identified in the temporal, prefrontal, and parietal cortices.
  • MI-based models outperformed models using Kullback-Leibler divergence, cross-entropy, cross-sample entropy, and correlation coefficients.

Conclusions:

  • MI-based connectomes reliably differentiate between normal controls, mild cognitive impairment, and Alzheimer's disease.
  • Mutual information demonstrates superior performance compared to other connectivity measures for AD detection.
  • Further validation on independent datasets is recommended for the MI-based connectome model.